Shield Therapeutics

(STX)
Sector: Pharmaceuticals & Biotechnology
2.82p
-0.03p -1.05
Last updated: 11:50:29

Share information

Name Shield Therapeutics
Epic STX
Isin GB00BYV81293
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 2.82p Net gearing n/a
Market capitalisation £22.05 Debt ratio n/a
Shares in issue 782.06 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE 5574.34
Dividend cover n/a EPS growth n/a
Earning per share -17 52-week high / low 1.23p / 7.65p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Shield Therapeutics
Address Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Telephone +44 (0) 191 511 8500
Website http://www.shieldtherapeutics.com/

Directors

Director Position
Dr Christian Schweiger Non-Executive Director
Mr Hans-Peter Hasler Non-Executive Chairman
Mr Greg Madison Group Chief Executive
Mr Peter Llewellyn-Davies Independent Non-Executive Director
Mr Anders Lundstrom Independent Non-Executive Director
Mrs Fabiana Lacerca Allen Independent Non-Executive Director

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 11.78 26.85 27.27
Investments and other non-current assets n/a n/a n/a
Total non-current assets 11.98 27.16 27.3
Inventory / work in progress 1.46 1.64 1.38
Trade and other receivables 5.38 2.93 0.62
Cash and equivalents 2.82 12.12 2.94
Other current assets and asset held for resale 0.44 0.58 0.29
Total of all assets 22.07 44.41 32.53
Liabilities £ (m) 2022 2021 2020
Short term liabilities 10.64 3.72 2.25
Long term liabilities 6.01 n/a n/a
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 16.65 3.72 2.25
Net assets £ (m) 2022 2021 2020
Net assets 5.43 40.69 30.28
Equity £ (m) 2022 2021 2020
Share capital 3.89 3.24 1.76
Minority interests n/a n/a n/a
Retained earnings -146.64 -106.94 -88.25
Share premium account 116.26 114.58 88.35
Total equity 5.43 40.69 30.28
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -40.41 -20.29 -2.15
Pre-tax profit -40.08 -19.91 -1.89